Advancements in mass spectrometry‐based proteomics have enabled experiments
encompassing hundreds of samples. While these large sample sets deliver much‐needed …

Carrying out large multicenter studies is one of the key goals to be achieved towards a faster
transfer of the radiomics approach in the clinical setting. This requires large-scale radiomics …

The impact of PET image acquisition and reconstruction parameters on SUV measurements
or radiomic feature values is widely documented. This scanner effect is detrimental to the …

Systemic characterisation of the human faecal microbiome provides the opportunity to
develop non-invasive approaches in the diagnosis of a major human disease. However …

Characterizing the multifaceted contribution of genetic and epigenetic factors to disease
phenotypes is a major challenge in human genetics and medicine. We carried out high …

Diffuse intrinsic pontine glioma (DIPG) is the most severe paediatric solid tumour, with no
significant therapeutic progress made in the past 50 years. Recent studies suggest that …

SOMAscan is an aptamer-based proteomics assay capable of measuring 1,305 human
protein analytes in serum, plasma, and other biological matrices with high sensitivity and …

Signaling abnormalities in immune responses in the small intestine can trigger chronic type
2 inflammation involving interaction of multiple immune cell types. To systematically …

Multicenter studies are needed to demonstrate the clinical potential value of radiomics as a
prognostic tool. However, variability in scanner models, acquisition protocols and …

Abstract ProteomicsDB (https://www. ProteomicsDB. org) started as a protein-centric in-
memory database for the exploration of large collections of quantitative mass spectrometry …